PB
Paul Bonanos
@biobonanos.bsky.social
I write some, I edit some
58 followers43 following175 posts
On the private capital side, here's a $100m round for UK antifungal company F2G Ltd., whose olorofim is in late-stage development for aspergillosis: f2g.com/press-releas...
F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US | F2G.
Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and existing investors MANCHESTER, Unit ...
PB
Paul Bonanos
@biobonanos.bsky.social
I write some, I edit some
58 followers43 following175 posts